Dodwell, D., Coombes, G., Bliss, J. M., Kilburn, L. S., Johnston, S., SoFEA Trial Management Grp, [Group Author] (2008) Combining fulvestrant (Faslodex (TM)) with continued oestrogen suppression in endocrine-sensitive advanced breast cancer: the SoFEA trial. CLINICAL ONCOLOGY, 20 (5). pp. 321-324. ISSN 0936-6555

Full text not available from this repository.

Item Type:	Editorial
Authors (ICR Faculty only):	Johnston, Stephen and Bliss, Judith
All Authors:	Dodwell, D., Coombes, G., Bliss, J. M., Kilburn, L. S., Johnston, S., SoFEA Trial Management Grp, [Group Author]
Uncontrolled Keywords:	2 MULTICENTER TRIALS; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; TAMOXIFEN; ANASTROZOLE; DEPRIVATION; EXEMESTANE; CARCINOMA; SUPERIOR; CELLS
Research teams:	Clinical Units > Breast Unit ICR divisions > Clinical Studies > Clinical Trials & Statistics Unit
Depositing User:	Users 10 not found.
Date Deposited:	01 Jul 2008 08:52
Last Modified:	10 Feb 2010 11:49
URI:	http://publications.icr.ac.uk/id/eprint/6483

Actions (login required)

View Item